Introduction

Third‑party risk in pharma requires more than vendor scorecards. It demands verifiable electronic records, defensible signature evidence, and closed‑loop quality handoffs that align with 21 CFR Part 11 expectations. Parakeet Risk unifies TPRM with pharma‑grade controls by combining automated supplier workflows, signature/audit evidence capture, and seamless exchanges with existing eQMS processes—while delivering real‑time regulatory awareness. See our pharma overview for context on Part 11 alignment and QMS integration in production environments: Pharmaceutical Compliance.

What “TPRM + 21 CFR Part 11” covers

Parakeet focuses Part 11–aligned control evidence across the supplier lifecycle:

• Qualification: approved‑supplier listing, questionnaires, due‑diligence notes, and quality/technical agreements.

• Operational oversight: deviations/complaints, change notifications, material/lot attestations, certificates, and COIs.

• Corrective and preventive action (CAPA): issue triage, containment, root cause analysis, actions, and effectiveness checks.

• Periodic review/re‑qualification: performance KPIs, audit findings, training confirmations, and re‑approvals. Each artifact is managed as an electronic record with provenance, user attribution, and time‑stamped activity trails, as described in Pharmaceutical Compliance and supported by platform capabilities on Features.

Evidence model: e‑signatures and audit trails

Parakeet operationalizes signature and audit evidence so TPRM records stand up during audits:

• Signature attestations bound to records: workflows record who signed, their stated meaning (e.g., approval, review, authorship), and the exact date/time; the signature entry is linked to the underlying artifact and its current version.

• Identity context: Parakeet stores the signer identity and capture method as provided by the source system (Parakeet or an integrated eQMS/contract system) and associates it with the event in the audit history.

• Versioned records and activity trails: every create/edit/review/approve is time‑stamped with user attribution; comments, attachments, and status changes are preserved to make the review path reconstructable.

• Review and export for auditors: produce point‑in‑time snapshots and evidence packets that include the artifact, signature events, and the audit trail, consistent with Part 11 expectations described on Pharmaceutical Compliance.

eQMS handoffs and closed‑loop quality

Parakeet integrates with your quality stack so third‑party issues flow into formal quality processes—and back:

• Deviation and change control initiation: a supplier issue detected in Parakeet can open a deviation or change request in the eQMS; the eQMS identifier is stored on the vendor record for traceability.

• CAPA synchronization: containment and corrective actions created in the eQMS are mirrored as tasks/evidence in Parakeet so TPRM owners can track effectiveness without duplicative work.

• Documented approvals: quality agreement revisions or procedural updates approved in the eQMS are reflected in Parakeet with signature event references and links back to the QMS source. Explore Parakeet’s QMS alignment in Pharmaceutical Compliance and integration patterns in Integrations.

Supplier onboarding and continuous assurance

• Certifications and insurance: automate collection, validation, and expiry tracking for supplier certificates and COIs with full documentation trails; see COI Automation.

• Operational collaboration: map remediation and review tasks to existing team tools with two‑way sync (e.g., Trello, Slack, Microsoft Teams) while preserving a single system of record in Parakeet.

• Spreadsheet synergy: keep institutional knowledge in existing Excel‑based trackers while Parakeet adds audit trails, workflows, and evidence packaging; see our perspective on augmenting spreadsheets in the blog article Reinventing industrial compliance without abandoning the mighty spreadsheet.

Regulatory intelligence for pharma workflows

Parakeet’s Rosella AI monitors evolving FDA/EMA guidance and turns changes into contextual tasks for affected suppliers, documents, and quality processes. Teams receive targeted alerts and can auto‑generate impact assessments and evidence summaries. Learn more about the agent on Rosella AI Compliance Agent and sector context on Pharmaceutical Compliance.

Controls‑to‑capability map

Implementation blueprint

• Define scope: suppliers in regulated product chains (CMO/CDMO/CRO/API/packaging) and in‑scope artifacts (agreements, questionnaires, CAPA, COIs, certifications).

• Configure records: standardize templates and metadata (owner, status, version, linked systems) in Parakeet.

• Enable signature capture: select capture points (review/approval), define meaning statements, and enable audit‑trail logging for each workflow step.

• Connect eQMS: map deviation/change/CAPA objects; store cross‑system IDs on supplier artifacts; test round‑trip synchronization.

• Automate alerts: turn on Rosella‑driven pharma regulatory monitoring; route updates to owners via Slack/Teams with links to affected records.

• Validate evidence flows: generate sample evidence packets for each artifact type and review with QA/CSV teams.

• Operate and improve: run periodic supplier reviews, track KPIs in dashboards, and refine workflows based on audit feedback (see Features).

Related resources

• Pharmaceutical Compliance

• Rosella AI Compliance Agent

• Integrations

• Features

• COI Automation